GERN : Summary for Geron Corporation - Yahoo Finance

U.S. Markets closed

Geron Corporation (GERN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.12+0.01 (+0.47%)
At close: 4:00PM EDT
People also watch
STEMARIAINCYEXELCTIC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.11
Open2.11
Bid1.98 x 100
Ask2.28 x 700
Day's Range2.09 - 2.15
52 Week Range1.81 - 3.35
Volume902,688
Avg. Volume1,432,698
Market Cap337.42M
Beta3.32
PE Ratio (TTM)-11.16
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire5 days ago

    Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma

    NEW YORK, NY / ACCESSWIRE / March 20, 2017 / As both Geron and Galena Biopharma show signs of biotech life with their FDA trial advancements, the stocks also have a common problem – how to convince investors ...

  • Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
    Capital Cube8 days ago

    Geron Corp. :GERN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017

    Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., CTI BioPharma Corp., Bio-Techne Corporation, Immunomedics, Inc. and Incyte Corporation (GILD-US, CTIC-US, TECH-US, IMMU-US and INCY-US) that have also reported for this period. ... Read more (Read more...)

  • Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube10 days ago

    Geron Corp. :GERN-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Geron Corp. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Geron Corp. – Gilead Sciences, Inc., Bio-Techne Corporation, Immunomedics, Inc., CTI BioPharma Corp. and Incyte Corporation (GILD-US, TECH-US, IMMU-US, CTIC-US and INCY-US) that have also reported for this period. ... Read more (Read more...)